International Clinical Trial: A Study to Evaluate the Pharmacokinetics and Safety of INCB161734 in Participants With Impaired Renal Function and Participants on Hemodialysis

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07854249) titled 'A Study to Evaluate the Pharmacokinetics and Safety of INCB161734 in Participants With Impaired Renal Function and Participants on Hemodialysis' on Sept. 28.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Incyte Corporation

Condition: Renal Insufficiency Kidney Diseases

Intervention: Drug: INCB161734

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: October 26, 2026

Target Sample Size: 24

To know more, visit https://clinicaltrials.gov/study/NCT...